Joint Formulary & PAD

Ethinylestradiol with etonogestrel - Contraception

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Vaginal insert
Associated Icons :
Restrictions / Comments :
Important

Note a cost-effective choice. Consider only if compliance / swallowing difficulties / malabsorption with oral CHC and LARC is unsuitable.

SyreniRing is lower cost than NuvaRing and does not require refrigeration

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Ethinylestradiol with etonogestrel
Indication :
Contraception
Group Name :
Keywords :
vaginal delivery system, combined hormonal contraceptive, CHC
Brand Names Include :
SyreniRing, NuvaRing
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0